More from the article ...

... The move would follow the FDA's requirement for updated warning labels on mRNA COVID-19 vaccines regarding myocarditis and pericarditis. The vaccines have been associated with a rare risk of myocarditis, which causes damage to heart muscle cells.

Earlier this week, Stanford University released a study showing that mRNA-based COVID-19 vaccines cause myocarditis in about one in every 140,000 recipients after the first dose. That rate rises to one in 32,000 after the second dose. Males under age 30 face the highest risk.

The study, however, found that COVID-19 itself is 10 times more likely to cause myocarditis than the vaccine. ...